A new goal for secondary prevention of cardiovascular diseases: the reduction of neutrophil count.
作者信息
Servi Stefano De, Landi Antonio
机构信息
Department of Molecular Medicine, University of Pavia, Pavia, 27100, Italy.
Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), University of Italian Switzerland, Lugano, CH-6900, Switzerland.
出版信息
Future Cardiol. 2024;20(10):517-519. doi: 10.1080/14796678.2024.2384239. Epub 2024 Aug 7.
Abstract
摘要
相似文献
1
A new goal for secondary prevention of cardiovascular diseases: the reduction of neutrophil count.心血管疾病二级预防的新目标：降低中性粒细胞计数。
Future Cardiol. 2024;20(10):517-519. doi: 10.1080/14796678.2024.2384239. Epub 2024 Aug 7.
2
Relationship Between Neutrophil Count and 90-Day Outcomes and Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial.急性缺血性卒中或短暂性脑缺血发作患者中性粒细胞计数与90天预后的关系及双联抗血小板治疗的效果：INSPIRES试验的事后分析
J Am Heart Assoc. 2025 Jul 15;14(14):e040492. doi: 10.1161/JAHA.124.040492. Epub 2025 Jul 14.
3
Neutrophil count as a risk factor for cardiovascular diseases: how can we manage it?中性粒细胞计数作为心血管疾病的危险因素：我们如何管理它？
J Cardiovasc Med (Hagerstown). 2024 Nov 1;25(11):759-765. doi: 10.2459/JCM.0000000000001668. Epub 2024 Sep 27.
4
Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis.秋水仙碱用于血管事件二级预防的长期试验：一项荟萃分析。
Eur Heart J. 2025 Jul 7;46(26):2552-2563. doi: 10.1093/eurheartj/ehaf174.
5
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.氯吡格雷联合阿司匹林与单用阿司匹林预防心血管事件的比较
Cochrane Database Syst Rev. 2017 Dec 14;12(12):CD005158. doi: 10.1002/14651858.CD005158.pub4.
6
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.氯吡格雷联合阿司匹林与单用阿司匹林预防心血管疾病的比较
Cochrane Database Syst Rev. 2007 Jul 18(3):CD005158. doi: 10.1002/14651858.CD005158.pub2.
7
Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.手机短信用于心血管疾病二级预防中的药物依从性。
Cochrane Database Syst Rev. 2024 Mar 27;3(3):CD011851. doi: 10.1002/14651858.CD011851.pub3.
8
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压（DASH）方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
9
Fibrates for secondary prevention of cardiovascular disease and stroke.贝特类药物用于心血管疾病和中风的二级预防。
Cochrane Database Syst Rev. 2015 Oct 25;2015(10):CD009580. doi: 10.1002/14651858.CD009580.pub2.
10
Antiplatelet agents and anticoagulants for hypertension.抗血小板药物和抗凝剂治疗高血压。
Cochrane Database Syst Rev. 2022 Jul 28;7:CD003186. doi: 10.1002/14651858.CD003186.pub4.
本文引用的文献
1
Clopidogrel induced reduction in neutrophil count: An overlooked beneficial effect?氯吡格雷导致的中性粒细胞计数减少：被忽视的有益作用？
Eur J Intern Med. 2024 Jun;124:32-34. doi: 10.1016/j.ejim.2024.03.026. Epub 2024 Apr 6.
2
Neutrophil counts and cardiovascular disease.中性粒细胞计数与心血管疾病。
Eur Heart J. 2023 Dec 14;44(47):4953-4964. doi: 10.1093/eurheartj/ehad649.
3
Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis.氯吡格雷与阿司匹林单药治疗对冠心病患者二级预防的疗效和安全性：一项荟萃分析。
Front Cardiovasc Med. 2023 Oct 17;10:1265983. doi: 10.3389/fcvm.2023.1265983. eCollection 2023.
4
P2Y Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events.P2Y 抑制剂或阿司匹林单药治疗用于冠心病事件的二级预防。
J Am Coll Cardiol. 2023 Jul 11;82(2):89-105. doi: 10.1016/j.jacc.2023.04.051.
5
Tailoring oral antiplatelet therapy in acute coronary syndromes: from guidelines to clinical practice.急性冠状动脉综合征中口服抗血小板治疗的个体化：从指南到临床实践
J Cardiovasc Med (Hagerstown). 2023 Feb 1;24(2):77-86. doi: 10.2459/JCM.0000000000001399. Epub 2022 Nov 15.
6
Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study.经皮冠状动脉介入治疗后阿司匹林与氯吡格雷用于长期维持单药治疗：HOST-EXAM扩展研究
Circulation. 2023 Jan 10;147(2):108-117. doi: 10.1161/CIRCULATIONAHA.122.062770. Epub 2022 Nov 7.
7
Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy.氯吡格雷和替格瑞洛对白细胞计数的差异影响与患者特征、生物标志物和基因型的关系：一项PLATO亚组研究
Platelets. 2022 Apr 3;33(3):425-431. doi: 10.1080/09537104.2021.1934667. Epub 2021 Jun 2.
8
The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials.中性粒细胞与淋巴细胞比值与动脉粥样硬化事件的关系：五项当代随机试验的分析。
Eur Heart J. 2021 Mar 1;42(9):896-903. doi: 10.1093/eurheartj/ehaa1034.
9
Antiplatelet Therapy in Elderly Patients with Acute Coronary Syndromes: the Clopidogrel Revenge: Possible Reasons for a Bright Comeback.老年急性冠状动脉综合征患者的抗血小板治疗：氯吡格雷的逆袭：强势回归的可能原因
Cardiovasc Drugs Ther. 2021 Apr;35(2):399-401. doi: 10.1007/s10557-020-07055-0. Epub 2020 Aug 18.
10
Association of Total and Differential Leukocyte Counts With Cardiovascular Disease and Mortality in the UK Biobank.总白细胞计数和白细胞分类计数与英国生物库心血管疾病和死亡率的关联。
Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1415-1423. doi: 10.1161/ATVBAHA.118.310945. Epub 2018 Apr 26.
Zotero 插件